Saturday, October 31, 2026

CBOE Went Down By Over 34% In The Last 21 Sessions

ViaNews Editorial Team

November 21, 2023

CBOE Went Down By Over 34% In The Last 21 Sessions

(VIANEWS) - CBOE (VIX) has been up by 34.12% for the last 21 sessions. At 15:08 EST on Tuesday, 21 November, CBOE (VIX) is $13.42.

About CBOE's yearly highs and lows, it's 0.22% up from its 52-week low and 61.71% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a negative 1.39%, a negative 2.38%, and a positive 4.99%, respectively.

CBOE's highest amplitude of average volatility was 1.95% (last week), 4.55% (last month), and 4.99% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be overbought (>=80).

News about

  • According to MarketWatch on Monday, 20 November, "The Dow Jones Industrial Average DJIA was up less than 0.1% soon after the opening bell, while the S&P 500 SPX edged up less than 0.1% and the Nasdaq Composite COMP rose 0.2%, according to FactSet data at last check. ", "Last week, the Dow, S&P 500 and Nasdaq each booked a third consecutive weekly gain, with the S&P 500 jumping 9.6% over the three-week period."
  • According to MarketWatch on Monday, 20 November, "The company, worth around $1.2 trillion now, is big enough that it is expected to be the largest driver of profit growth for the S&P 500 index SPX overall for the third quarter."
  • According to MarketWatch on Monday, 20 November, "The stock has gained 15% in the year to date, while the S&P 500 SPX has gained 17.6%."
  • According to Zacks on Monday, 20 November, "Combining the actual results with those for companies that have yet to report, total S&P 500 earnings are on pace to increase 2.8% from the same period last year on 1.9% higher revenues."

More news about CBOE (VIX).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com